237 related articles for article (PubMed ID: 35564639)
1. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers.
Zhang K; Fang Y; Chan PS; Cao H; Chen H; Hu T; Chen Y; Zhou X; Wang Z
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564639
[TBL] [Abstract][Full Text] [Related]
2. Behavioral Intention to Receive a COVID-19 Vaccination Among Chinese Factory Workers: Cross-sectional Online Survey.
Zhang KC; Fang Y; Cao H; Chen H; Hu T; Chen Y; Zhou X; Wang Z
J Med Internet Res; 2021 Mar; 23(3):e24673. PubMed ID: 33646966
[TBL] [Abstract][Full Text] [Related]
3. Parental Acceptability of COVID-19 Vaccination for Children Under the Age of 18 Years: Cross-Sectional Online Survey.
Zhang KC; Fang Y; Cao H; Chen H; Hu T; Chen YQ; Zhou X; Wang Z
JMIR Pediatr Parent; 2020 Dec; 3(2):e24827. PubMed ID: 33326406
[TBL] [Abstract][Full Text] [Related]
4. An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China.
Hu T; Li L; Lin C; Yang Z; Chow C; Lu Z; You C
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206495
[TBL] [Abstract][Full Text] [Related]
5. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
Front Public Health; 2022; 10():914950. PubMed ID: 35903387
[TBL] [Abstract][Full Text] [Related]
6. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():986916. PubMed ID: 36589991
[TBL] [Abstract][Full Text] [Related]
7. Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey.
Huang X; Yu M; Fu G; Lan G; Li L; Yang J; Qiao Y; Zhao J; Qian HZ; Zhang X; Liu X; Jin X; Chen G; Jiang H; Tang W; Wang Z; Xu J
JMIR Public Health Surveill; 2021 Oct; 7(10):e31125. PubMed ID: 34543223
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey.
Alobaidi S; Hashim A
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891150
[TBL] [Abstract][Full Text] [Related]
9. Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China.
Pan SJ; Yang YP; Zhang MX; Tung TH
Hum Vaccin Immunother; 2022 Nov; 18(5):2063629. PubMed ID: 35522922
[TBL] [Abstract][Full Text] [Related]
10. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
[TBL] [Abstract][Full Text] [Related]
11. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
[TBL] [Abstract][Full Text] [Related]
12. A study on the factors influencing the intention to receive booster shots of the COVID-19 vaccine in China based on the information frame effect.
Zhu Q; Gao Y; Hu Q; Hu D; Wu X
Front Public Health; 2024; 12():1258188. PubMed ID: 38444439
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with behavioral intention of free and self-paid severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination based on the social cognitive theory among nurses and doctors in China.
She R; Chen X; Li L; Li L; Huang Z; Lau JTF
Infect Control Hosp Epidemiol; 2022 May; 43(5):609-615. PubMed ID: 33938413
[TBL] [Abstract][Full Text] [Related]
14. Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China.
Lan X; Su B; Liang S; Yu M; Qiao Y; Wang L; Song M; Wang Y; Xu J
Front Public Health; 2023; 11():1227277. PubMed ID: 37680268
[TBL] [Abstract][Full Text] [Related]
15. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine acceptance among cold-chain workers in Shenzhen, China: A cross-sectional survey.
Liu L; Zhang M; Chen H; Xian J; Cao H; Zhou X; Gu Z; Liu H; Li Q; Wu F; Chen Q; Lin Q
Hum Vaccin Immunother; 2022 Nov; 18(5):2056400. PubMed ID: 35468306
[TBL] [Abstract][Full Text] [Related]
17. College students' influence on COVID-19 vaccination uptake among seniors in China: a protocol of combined cross-sectional and experimental study.
Bian J; Guo Z; Zhang W; Li X; Sun C; Xu X; Zou H
BMC Public Health; 2023 Jul; 23(1):1322. PubMed ID: 37430252
[TBL] [Abstract][Full Text] [Related]
18. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China.
Wu F; Yuan Y; Deng Z; Yin D; Shen Q; Zeng J; Xie Y; Xu M; Yang M; Jiang S; Zhang C; Lu H; Sun C
J Med Virol; 2022 Sep; 94(9):4115-4124. PubMed ID: 35506329
[TBL] [Abstract][Full Text] [Related]
19. Assessing the acceptability of COVID-19 vaccine and its booster dose.
Mubarak S; A'aqoulah A; AlGhawrie H; Albalas S; Innab N
Immun Inflamm Dis; 2023 Sep; 11(9):e950. PubMed ID: 37773710
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
